These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 11812902)

  • 1. Cardiovascular calcification in end-stage renal disease.
    Salusky IB; Goodman WG
    Nephrol Dial Transplant; 2002 Feb; 17(2):336-9. PubMed ID: 11812902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular calcification in end stage renal disease.
    Raggi P
    Contrib Nephrol; 2005; 149():272-278. PubMed ID: 15876850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Why do patients with kidney diseases end up with a heart of stone? Disturbances in calcium-phosphate balance and chronic inflammation important causes].
    Martola L; Elinder CG; Stenvinkel P
    Lakartidningen; 2003 Dec; 100(50):4180-3. PubMed ID: 14717005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular calcification in patients with end-stage renal disease: a century-old phenomenon.
    Qunibi WY; Nolan CA; Ayus JC
    Kidney Int Suppl; 2002 Dec; (82):S73-80. PubMed ID: 12410860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of hyperphosphataemia in the cardio-renal axis.
    Goodman WG
    Nephrol Dial Transplant; 2004 Mar; 19 Suppl 1():i4-8. PubMed ID: 15126647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethiopathogenesis, diagnosis and prevention of vascular calcification in end stage renal disease.
    Ferramosca E; Bellasi A; Ratti C; Raggi P
    Curr Med Chem Cardiovasc Hematol Agents; 2005 Apr; 3(2):165-71. PubMed ID: 15853703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mineral metabolism disturbances in patients with chronic kidney disease.
    Kestenbaum B; Belozeroff V
    Eur J Clin Invest; 2007 Aug; 37(8):607-22. PubMed ID: 17635571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular calcification in nondialyzed patients with chronic kidney disease.
    Qunibi WY
    Semin Dial; 2007; 20(2):134-8. PubMed ID: 17374087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoparathyroidism potentiates cardiovascular complications through disturbed calcium metabolism: possible risk of vitamin D(3) analog administration in dialysis patients with end-stage renal disease.
    Tsuchihashi K; Takizawa H; Torii T; Ikeda R; Nakahara N; Yuda S; Kobayashi N; Nakata T; Ura N; Shimamoto K
    Nephron; 2000 Jan; 84(1):13-20. PubMed ID: 10644903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular calcification in dialysis patients: pathogenesis and consequences.
    Reslerova M; Moe SM
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S96-9. PubMed ID: 12612962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recent advances in the prevention of cardiovascular morbidity and mortality in end-stage renal disease: role of anemia, hyperparathyroidism and calcifications].
    Del Vecchio L; Pozzoni P; Limardo M; Caruso S; Fortunato M; Pontoriero G; Locatelli F
    G Ital Nefrol; 2007; 24 Suppl 38():25-32. PubMed ID: 17922444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hyperphosphatemia and cardiovascular risk in patients on dialysis].
    Basić-Jukić N; Kes P
    Acta Med Croatica; 2004; 58(3):207-13. PubMed ID: 15503684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging of cardiovascular calcifications with electron beam tomography in hemodialysis patients.
    Raggi P
    Am J Kidney Dis; 2001 Jan; 37(1 Suppl 2):S62-5. PubMed ID: 11158864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiovascular risk in women with chronic renal failure: mammographic study of vascular calcifications].
    Canabal A; Sabate J; Salgueira M; Palma A
    Radiologia; 2008; 50(1):54-60. PubMed ID: 18275790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Can cardiovascular calcifications be prevented in chronic kidney disease?].
    Coen G; Manni M; Mantella D; Splendiani G
    G Ital Nefrol; 2006; 23 Suppl 34():S21-5. PubMed ID: 16633990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cardiovascular burden of end-stage renal disease patients.
    Cianciolo G; Donati G; La Manna G; Ferri A; Cuna V; Ubaldi G; Corsini S; Lanci N; Colì L; Stefoni S
    Minerva Urol Nefrol; 2010 Mar; 62(1):51-66. PubMed ID: 20424570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorus restriction and control of coronary calcification as assessed by electron beam tomography.
    Raggi P; Ali O
    Curr Opin Nephrol Hypertens; 2002 Jul; 11(4):391-5. PubMed ID: 12105388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary calcification in patients with end-stage renal disease: a novel endocrine disorder?
    Efstratiadis G; Koskinas K; Pagourelias E
    Hormones (Athens); 2007; 6(2):120-31. PubMed ID: 17704043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of excess calcium load on the cardiovascular system measured with electron beam tomography in end-stage renal disease.
    Raggi P
    Nephrol Dial Transplant; 2002 Feb; 17(2):332-5. PubMed ID: 11812901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel cardiovascular risk factors in end-stage renal disease.
    Zoccali C; Mallamaci F; Tripepi G
    J Am Soc Nephrol; 2004 Jan; 15 Suppl 1():S77-80. PubMed ID: 14684678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.